Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Propofol
Therapeutic Area : Neurology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Avet Pharmaceuticals Announces Approval and Launch of Propofol Injectable Emulsion, USP
Details : Propofol injectable emulsion, an AB-rated generic equivalent of DIPRIVAN® (propofol) Injectable Emulsion USP is an intravenous general anesthetic and sedation drug indicated for initiation and maintenance of Monitored Anesthesia Care (MAC) sedation.
Product Name : Propofol-Generic
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 04, 2022
Lead Product(s) : Propofol
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable